MLICM
SWTX

Metropolitan Life Insurance Company (MetLife)’s SpringWorks Therapeutics SWTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,670
Closed -$181K – 1872
2024
Q1 		$181K Sell
3,670
-206
-5% -$9.52K 0.01% 758
2023
Q4 		$141K Buy
3,876
+512
+15% +$13.4K 0.01% 908
2023
Q3 		$77.8K Buy
3,364
+179
+6% +$4.89K ﹤0.01% 1159
2023
Q2 		$83.5K Buy
+3,185
New +$83.7K ﹤0.01% 1117
2023
Q1 		– Sell
-2,154
Closed -$56K – 2457
2022
Q4 		$56K Buy
2,154
+248
+13% +$6.11K ﹤0.01% 1403
2022
Q3 		$54.4K Hold
1,906
– – ﹤0.01% 1412
2022
Q2 		$46.9K Hold
1,906
– – ﹤0.01% 1548
2022
Q1 		$108K Sell
1,906
-5,529
-74% -$316K ﹤0.01% 1151
2021
Q4 		$461K Sell
7,435
-644
-8% -$42.6K 0.01% 1492
2021
Q3 		$513K Buy
+8,079
New +$623K 0.01% 1448
2021
Q2 		– Sell
-6,439
Closed -$474K – 2870
2021
Q1 		$474K Sell
6,439
-217
-3% -$17K 0.01% 1455
2020
Q4 		$483K Hold
6,656
– – 0.01% 1373
2020
Q3 		$317K Hold
6,656
– – 0.01% 1508
2020
Q2 		$280K Buy
6,656
+3,132
+89% +$111K 0.01% 1593
2020
Q1 		$95.1K Sell
3,524
-2,336
-40% -$76.2K ﹤0.01% 2054
2019
Q4 		$226K Buy
+5,860
New +$137K ﹤0.01% 1831

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SWTX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SpringWorks Therapeutics (SWTX) in Q2 2024, closing a stake of 3,670 shares — an estimated $181K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SWTX in Q4 2019 and held it in 16 quarters. The position peaked at $513K in Q3 2021. 209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining SpringWorks Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,670 SpringWorks Therapeutics shares in Q2 2024, an estimated $181K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 16 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s SpringWorks Therapeutics position peaked at $513K in Q3 2021.
  • 209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.